Public list: Smart Money VCs (6326) Pharma Startups (6570) Cancer Therapeutics (1180) Google In Healthcare (60)
RAPT Therapeutics (NASDAQ: RAPT) is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. ...Show all
Company (IPO / Went public)
Phone: 650-489-9000
561 Eccles Avenue
South San Francisco, 94080
California, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereof | Nov 13, 2018 | Jul 28, 2020 | Patent |
Chemokine receptor modulators and uses thereof | Jan 24, 2019 | Jun 16, 2020 | Patent |
Chemokine receptor modulators and uses thereof | Nov 19, 2018 | Mar 31, 2020 | Patent |
Chemokine receptor modulators and uses thereof | Sep 08, 2017 | Apr 02, 2019 | Patent |
Chemokine receptor modulators and uses thereof | Jul 28, 2017 | Jan 15, 2019 | Patent |